Deutsche Märkte öffnen in 2 Stunden 56 Minuten

Omnicell, Inc. (OMCL)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
28,43+0,25 (+0,89%)
Börsenschluss: 04:00PM EDT
28,43 0,00 (0,00%)
Nachbörse: 04:02PM EDT

Omnicell, Inc.

4220 North Freeway
Suite 301
Fort Worth, TX 76137
United States
877 415 9990
https://www.omnicell.com

Sektor(en)Healthcare
BrancheHealth Information Services
Vollzeitmitarbeiter3.650

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Randall A. LippsFounder, Executive Chairman, President & CEO1,85MN/A1957
Mr. Nchacha E. EttaExecutive VP & CFO480,21kN/A1972
Mr. Corey J. ManleyExecutive VP, Chief Legal & Administrative Officer and Corporate Secretary715,33kN/A1978
Ms. Minoo MortazaviSenior Vice President of Global OperationsN/AN/AN/A
Mr. Brian H. NuttVP, Chief Accounting Officer & Corporate ControllerN/AN/A1970
Mr. Giri ChodavarapuSenior VP & Chief Information OfficerN/AN/AN/A
Ms. Kathleen NemethSenior Vice President of Investor RelationsN/AN/AN/A
Mr. Maximo RochaSenior VP & Chief People OfficerN/AN/AN/A
Mr. Joseph Brian SpearsExecutive AdviserN/AN/A1960
Ms. Sara DalmassoSenior VP & GM of InternationalN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Corporate Governance

Omnicell, Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 4. Die grundlegenden Scores sind Audit: 1, Vorstand: 6, Shareholderrechte: 7, Kompensation: 3.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.